Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis

Clinical trial NCT00420927 · COMPLETED

Trial details

NCT number: NCT00420927
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2006-12-01
Primary completion: 2010-07-01
Enrollment: 1032

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.